KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer.

Pupo, Emanuela; Avanzato, Daniele; Middonti, Emanuele; Bussolino, Federico; Lanzetti, Letizia

Pupo, Emanuela; Avanzato, Daniele; Middonti, Emanuele; Bussolino, Federico; Lanzetti, Letizia.

Afiliação

Pupo E; Department of Oncology, University of Torino Medical School, Turin, Italy.
Avanzato D; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
Middonti E; Department of Oncology, University of Torino Medical School, Turin, Italy.
Bussolino F; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy.
Lanzetti L; Department of Oncology, University of Torino Medical School, Turin, Italy.

Front Oncol ; 9: 848, 2019.

Article em En | MEDLINE | ID: mdl-31544066

Palavras-chave

KRAS; NSCLC; PDAC; gluocose metabolism in cancer; glycolysis; metabolic adaptability in cancer; metabolic rewiring

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google